Martingale Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Hold |
47,014
| – | – | 0.01% | 738 |
|
|
2025
Q1 | $305K | Hold |
47,014
| – | – | 0.01% | 678 |
|
|
2024
Q4 | $345K | Sell |
47,014
-12
| -0% | -$88 | 0.01% | 666 |
|
|
2024
Q3 | $352K | Buy |
47,026
+104
| +0.2% | +$779 | 0.01% | 687 |
|
|
2024
Q2 | $418K | Buy |
46,922
+898
| +2% | +$7.99K | 0.01% | 638 |
|
|
2024
Q1 | $466K | Sell |
46,024
-19
| -0% | -$192 | 0.01% | 631 |
|
|
2023
Q4 | $463K | Buy |
46,043
+9,834
| +27% | +$98.9K | 0.01% | 630 |
|
|
2023
Q3 | $339K | Buy |
36,209
+10,122
| +39% | +$94.8K | 0.01% | 669 |
|
|
2023
Q2 | $640K | Buy |
26,087
+912
| +4% | +$22.4K | 0.01% | 560 |
|
|
2023
Q1 | $586K | Buy |
25,175
+8,208
| +48% | +$191K | 0.01% | 581 |
|
|
2022
Q4 | $429K | Buy |
16,967
+6,401
| +61% | +$162K | 0.01% | 650 |
|
|
2022
Q3 | $204K | Buy |
+10,566
| New | +$204K | ﹤0.01% | 780 |
|
|
2021
Q1 | – | Sell |
-9,523
| Closed | -$256K | – | 924 |
|
|
2020
Q4 | $256K | Buy |
+9,523
| New | +$256K | ﹤0.01% | 780 |
|